Treace Announces Participation in the Morgan Stanley 19th Annual Global Healthcare Conference
September 02 2021 - 4:05PM
Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a
commercial-stage orthopaedic medical device company driving a
paradigm shift in the surgical treatment of hallux valgus (commonly
known as bunions) through its Lapiplasty® 3D Bunion Correction™
procedure, today announced that John T. Treace, Chief Executive
Officer, and Mark Hair, Chief Financial Officer, will participate
in a virtual fireside chat at the Morgan Stanley 19th Annual Global
Healthcare Conference on Tuesday, September 14, 2021, beginning at
approximately 4:15 pm ET.
A live webcast and replay of the fireside chat
will be available on the Company’s investors relations website at
https://investors.treace.com/.
About Treace Medical
ConceptsTreace Medical Concepts, Inc. is a
commercial-stage orthopaedic medical device company with the goal
of advancing the standard of care for the surgical management of
bunion deformities. Bunions are complex 3-dimensional deformities
that originate from an unstable joint in the middle of the foot.
Treace has pioneered and patented the Lapiplasty® 3D Bunion
Correction™ system - a combination of instruments, implants, and
surgical methods designed to correct all 3 planes of the bunion
deformity and secure the unstable joint, addressing the root cause
of the bunion and getting patients back to their active lives
quickly.
Contacts:Treace Medical
ConceptsMark L. HairChief Financial
Officermhair@treace.net(904) 373-5940
Investors:Gilmartin GroupLynn
Lewis or Vivian CervantesIR@treace.net
Treace Medical Concepts (NASDAQ:TMCI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Treace Medical Concepts (NASDAQ:TMCI)
Historical Stock Chart
From Apr 2023 to Apr 2024